In a subset of patients that had experienced a previous stroke or transient ischemic attack (TIA), treatment with the investigational drug apixaban resulted in a reduced rate of stroke and systemic embolism compared with warfarin, according to a recent subset analysis of a major clinical trial. Stroke is the third-leading…
Read more »
The World Health Organization (WHO) estimates that about 1.5 million cases of new stroke occur in India each year, resulting in a loss of over 6 million disability-adjusted life-years (DALYs) annually. In a new multicenter, post-hoc analysis of patient registries including more than 1,800 ischemic stroke suffers treated with intravenous…
Read more »
About 1.44 to 1.64 million cases of new stroke occur each year in India, with stroke sufferers losing over 6 million disability-adjusted life years (DALYs) annually due to death and disability, according to data from the World Health Organization (WHO). Thrombolysis with recombinant tissue plasminogen activator (rt-PA) is used to…
Read more »
mdCurrent Conference Report: International Stroke Conference Warfarin did not reduce the rate of the combined endpoint of death, ischemic stroke, or intracerebral hemorrhage compared with aspirin, according to a Late Breaking Clinical Trial presented at the 2012 International Stroke Conference. Both warfarin and aspirin are used in this clinical setting,…
Read more »
indicates a Peer-Reviewed Article
Antibiotics for treating acute ischemic stroke—a novel idea?
Minocycline 200 mg once daily taken at the time of first stroke symptoms may aid in improving clinical deficits following an acute ischemic stroke (AIS), but more robust and better controlled clinical studies are needed before the antibiotic can be recommended for this indication. “There is an urgent need to…
Read more »